Today
@today·5M subscribers·54.4K videos
Why Pfizer ended testing on once-daily weight-loss pill treatment
Posted
April 15, 2025
Views
2,177
Likes
13
Engagement
0.60%
April 15, 2025
2,177
13
0.60%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:49Now PlayingPfizer announced it is ending its development of a once-daily weight-loss pill treatment for obesity. It comes after a participant in one of the trials experienced a possible drug-induced liver injury and recovered after the medication was stopped.
» Subscribe to TODAY
About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY's Website
Find TODAY on Facebook
Follow TODAY on Twitter
Follow TODAY on Instagram
» Stream TODAY All Day
About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place.
#pfizer #obesity #weightloss
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
